SUMATRIPTAN MYLAN 100 MG TBL FLM 2

Rychlý přehled

Dosage form Tablets film-coated
Výdej Ne, lék nelze získat bez receptu.
Úhrada / doplatek / cena Ano, podmínky úhrady (vykazovací limit) ale nebyl stanoven. Maximální doplatek: 70,43 Kč. Maximální cena: 111,41 Kč.
Kdo může předepsat Prescription is not conditional on a medical specialization.
Složení Sumatriptan-sukcinát (140 mg), sumatriptan (100 mg), monohydrát laktosy, mikrokrystalická celulosa, granulovaná mikrokrystalická celulosa, kroskarmelosa, magnesium-stearát, potahová soustava opadry ii y-22-7719 bílá. Da…
Dostupnost / výpadek Ukončeno The latest report from the manufacturer is from 10. 5. 2024. Výroba byla ukončena s platností od 16. 5. 2024. The manufacturer lists medicines with the following code as a potential substitute: 0269075
Kód SÚKL 0234931

What is the maximum co-payment for SUMATRIPTAN MYLAN?

If the insurance company contributes, the maximum co-payment is 70,43 Kč. The maximum pharmacy price is 111,41 Kč. A pharmacy may provide the medicine for a lower price, but not for a higher price.

Does the medicine have reimbursement from public health insurance?

Yes, but the reimbursement conditions (reporting limit) have not been set.

Does SUMATRIPTAN MYLAN have a counted co-payment set?

Yes, the medicine has a counted co-payment of 54,00 Kč. Learn more about the protective limit here.

How much does the insurance company pay for one dispensed reimbursed pack?

40,98 Kč.

Does the insurance company pay a higher amount in some cases?

No, the medicine has no increased reimbursement.

Does the medicine have an indication restriction?

The medicine has no indication restriction. Its reimbursement is not conditional on a specific diagnosis or clinical condition.

Is it available without a medical prescription?

No, the medicine cannot be obtained without a prescription.

Which medical specialist may prescribe SUMATRIPTAN MYLAN?

Prescription is not conditional on a medical specialization.

What is the composition of SUMATRIPTAN MYLAN?

Sumatriptan-sukcinát (140 mg), sumatriptan (100 mg), monohydrát laktosy, mikrokrystalická celulosa, granulovaná mikrokrystalická celulosa, kroskarmelosa, magnesium-stearát, potahová soustava opadry ii y-22-7719 bílá. More information about the composition can be found in the SPC, section 6.1.

Where can I find information about correct use of the medicine?

  • Documents could not be found

Which medicines are similar to SUMATRIPTAN MYLAN?

The medicine belongs to ATC group N02CC01 – Sumatriptan. Medicines with the same active substance can be found here.

Who manufactures SUMATRIPTAN MYLAN?

Informace o výrobci není dostupná.

Is the medicine in shortage?

The latest report from the manufacturer is from 10. 5. 2024. Production was terminated with effect from 16. 5. 2024. The manufacturer lists medicines with the following code as a potential substitute:

What is the unique code for SUMATRIPTAN MYLAN?

The medicine has code 0234931. Code details can be found here.

How many packs of SUMATRIPTAN MYLAN were previously dispensed on prescriptions in Czechia?

Show prescription medicine consumption

How many packs of SUMATRIPTAN MYLAN were previously dispensed on request forms in Czechia?

Show request-form medicine consumption

Z čeho se skládá maximální cena léku?

The page was last updated on 17. 07. 2026

SIMILAR MEDICINES: